Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: Hepatology. 2021 Jun 15;74(3):1371–1383. doi: 10.1002/hep.31803

Figure 1. Training and validation phase of a transcriptomic panel for the identification of recurrence in patients with ICC.

Figure 1.

A) A ROC curve for a transcriptomic panel in tissue specimens from training cohort patients (with recurrence = 37, non-recurrence = 27, AUC = 0.89). B) Risk score distribution plot in training cohort patients. Modified risk scores were obtained from individual risk scores by using Youden’s index values from the risk model. C) A ROC curve for the transcriptomic panel in tissue specimens from validation cohort patients (with recurrence = 109, non-recurrence = 68, AUC = 0.86). D) Risk score distribution plot in validation cohort patients.